The 2nd AAPP Summit Commences Next Week, Oct. 6-7: Register Now

Overdose deaths are higher than ever, the demand for adolescent substance use services outstrip availability, and mental health and substance use workforce shortages are all too real. AAPP believes psychiatric pharmacists are poised to be part of the solution to these crises.

The 2022 Summit, a 2-day virtual event, features 8 sessions over 2 days of cutting-edge information, preparing you to meet patients where they are as they seek care and recovery. Join us to learn and update your knowledge and skill on current issues such as chronic cannabis use, pre-exposure prophylaxis (PrEP) for HIV in persons who inject drugs, managing the complexities of co-occurring opioid use disorder (OUD) and alcohol use disorder (AUD), and more, and earn 10 hours of ACPE and BCPP recertification credit.

The 2^nd AAPP Summit is being presented by AAPP’s Substance Use Disorders Education Committee with Sarah Melton, PharmD, BCPP, BCACP, FASCP serving as chair. The planning committee has been hard at work finalizing a fantastic line-up of sessions:

Thursday, Oct. 6

1. A New Wave of Cannabis Concerns: The Potential Sequela of Chronic Cannabis Use, presented by Kari Franson, PharmD, PhD, BCPP
2. Why Do I Need to Taper? Challenges and Evidence Behind Benzodiazepine Discontinuation, presented by Kristina Ward, PharmD, BCPS, BCPP
3. Pre-exposure Prophylaxis (PrEP) for HIV in Persons Who Inject Drugs, presented by Jacqueline Byrd, PharmD, BCPS, AAHIVP
4. The Revolving Door: Improving Transitions of Care for Incarcerated Persons with Opioid Use Disorder, presented by David Dadiomov, PharmD, BCPP

Friday, Oct. 7

1. Therapeutic Uses of Psychedelics, presented by Frederick S. Barrett, PhD
2. A Case-Based Approach to Managing the Complexities of Co-Occurring OUD and AUD, presented by Michelle Colvard, PharmD, BCPP
3. A Stimulating Discussion on Stimulant Use Disorder, presented by Phillip Coffin, MD, MIA, VACP, FIDCA
4. Recognizing and Managing Co-occurring Substance Use and Eating Disorders, presented by Danielle Stutzman, PharmD, BCPP

After attending this Summit, participants will be able to:

1. Implement evidence-based guidelines and principles into the evaluation and treatment of patients with substance use disorders.
2. Demonstrate a patient-centered approach to the care of patients with substance use disorders with attention to decreasing barriers and improving access to care.
3. Evaluate harm reduction approaches to caring for patients with substance use disorders.

This virtual event is open to AAPP members and non-members and has special pricing for residents/fellows and students! Check out the schedule and register now to join us virtually Oct. 6-7. Session recordings will be made available to registrants following the event.